Computed tomography assessment of ablation zone enhancement in patients with early-stage lung cancer after Stereotactic ablative radiotherapy

Journal of Computer Assisted Tomography

Volumn 39, Issue 5, 2015, Pages 804-809

  Moore, William ^a   Chaya, Yair ^a   Chaudhry, Ammar ^a   Depasquale, Britney ^a   Glass, Samantha ^a   Lee, Susan ^a   Shin, James ^a   Mikhail, George ^a   Bhattacharji, Priya ^a   Kim, Bong ^a   Bilfinger, Thomas ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Ablation; CT; Early stage lung cancer; SABR

Indexed keywords

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DISEASES; RADIOTHERAPY; SURGERY;

AFTER-TREATMENT; COMPUTED TOMOGRAPHY; CONTRAST-ENHANCED; EARLY-STAGE LUNG CANCERS; FOLLOW UP; INSTITUTIONAL REVIEW BOARDS; LUNG CANCER; LUNG INJURY; RADIATION-INDUCED; STEREOTACTIC ABLATIVE RADIOTHERAPIES;

ABLATION;

CONTRAST MEDIUM;

ABLATION ZONE; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED RADIOTHERAPY; CONE BEAM COMPUTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MEDICAL RECORD REVIEW; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION ONCOLOGIST; RADIOLOGICAL PARAMETERS; RADIOTHERAPY PLANNING SYSTEM; RETROSPECTIVE STUDY; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC DEVICE; STEREOTACTIC TREATMENT; TUMOR VOLUME; COMPUTER ASSISTED TOMOGRAPHY; IMAGE QUALITY; LUNG; LUNG NEOPLASMS; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; RADIOSURGERY; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOSURGERY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84941901825     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0000000000000262     Document Type: Article

References (13)

1. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070-1076.
2. Takeda A, Yokosuka N, Ohashi T, etal. The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SABR). Radiother Oncol. 2011;101:291-297.
3. Clarke K, Taremi M, Dahele M, et al. Stereotactic body radiotherapy (SABR) for non-small cell lung cancer (NSCLC): is FDG-PETa predictor of outcome? Radiother Oncol. 2012;104:62-66.
4. Bollineni VR, Widder J, Pruim J, et al. Residual 18F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Int J Radiat Oncol Biol Phys. 2012;83:e551-e555.
5. Hoopes DJ, Tann M, Fletcher JW, et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer. 2007;56:229-234.
6. Burdick MJ, Stephans KL, Reddy CA, et al. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:1033-1039.
7. Zhang X, Liu H, Balter P, et al. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83:1558-1565.
8. Dunlap NE, Yang W, McIntosh A, et al. Computed Tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;84:1070-1077.
9. Takeda A, Kunieda E, Takeda T, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:1057-1065.
10. Matsuo Y, Nagata Y, Mizowaki T, et al. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol. 2007;12:356-362 Epub 2007 Oct.
11. Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology. 2004;233(1):191-199.
12. Schaefer JF, Vollmar J, Schick F, et al. Solitary pulmonary nodules: dynamic contrast-enhanced mr imaging-perfusion differences in malignant and benign lesions. Radiology. 2004;232:544-553.
13. Song CW, Kim MS, Cho LC, et al. Radiobiological basis of SBRT and SRS. Int J Clin Oncol 2014;19:570-578.